JPRN-UMIN000019669Completed未知
Effect of phosphate binder on serum level of FGF23: A comparison between ferric citrate hydrate and lanthanum carbonate. - Effect of phosphate binder on FGF23.
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Hyogo College of Medicine
- Enrollment
- 20
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with iron excess
Investigators
Similar Trials
Completed
Early Phase 1
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseChronic Kidney DiseaseNCT01308242Milton S. Hershey Medical Center40
Recruiting
Not Applicable
phosphorus intake and FGF23 blood levelshet gaat om gezonde proefpersonenniet van toepassingNL-OMON31826Vrije Universiteit Medisch Centrum10
Active, not recruiting
Phase 1
levels of the hormone FGF23 in healthy volunteers with a low phosphate levelhealthy volunteersthe information of this pilot study will be used in the care of patients with hypophosphatemia due to renal phosphate wastingEUCTR2016-002602-39-NLRadboud University Medical Center
Completed
Not Applicable
FGF23 response in hypophosphatemialow bood phosphate level10029149hypophosphatemiaNL-OMON42928Radboud Universitair Medisch Centrum10
Completed
Not Applicable
FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseSecondary HyperparathyroidismNCT00999037University of California, Los Angeles18